REQUEST A DEMO
Total
USD $0.00
Search more companies

Lifehealth Universal Col Zomac S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Lifehealth Universal Col Zomac S.A.S. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Lifehealth Universal Col Zomac S.A.S. is an enterprise based in Colombia. Its main office is in Salento. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on March 28, 2018. 14 (2024) employees currently work for Lifehealth Universal Col Zomac S.A.S.. From the latest financial highlights, Lifehealth Universal Col Zomac S.A.S. reported a net sales revenue increase of 25.57% in 2023. A growth of 4.8% was recorded in its total assets. The net profit margin of Lifehealth Universal Col Zomac S.A.S. increased by 5.14% in 2023.

Headquarters
Vda San Juan de Carolina Fca El Danubio Piso 2
Salento; Quindio;

Contact Details: Purchase the Lifehealth Universal Col Zomac S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Lifehealth Universal Col Zomac S.A.S. report to view the information.
Outstanding Shares:
Purchase the Lifehealth Universal Col Zomac S.A.S. report to view the information.
Incorporation Date:
March 28, 2018
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Lifehealth Universal Col Zomac S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
25.57%
Total operating revenue
28.18%
Operating profit (EBIT)
76.1%
Net Profit (Loss) for the Period
59.41%
Total assets
4.8%
Total equity
2.52%
Operating Profit Margin (ROS)
7.67%
Net Profit Margin
5.14%
Return on Equity (ROE)
0.94%
Debt to Equity Ratio
-5.15%
Quick Ratio
-8.64%
Cash Ratio
-20.6%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?